California FCA Strengthened to Parallel the Federal Act
Client Alert | less than 1 min read | 10.23.12
On September 27, Governor Brown signed into law amendments to the California False Claims Act predominantly designed to strengthen the CFCA and conform it to the federal FCA. The new law, which takes effect on January 1, 2013, increases incentives to bring lawsuits against state and local contractors by broadening anti-retaliation provisions, raising the amount of civil penalties recoverable, facilitating whistleblower suits, and extending liability for retention of an overpayment.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
